Andy Bell

Andy Bell has extensive work experience in the pharmaceutical industry. Andy served as the EVP Medicinal Chemistry at Exscientia since May 2021, and prior to that, they held the position of Chief Research Officer. Before joining Exscientia, they worked as the Head of Medicinal Chemistry from April 2014 to August 2018. Prior to their role at Exscientia, Andy was a Research Fellow at Imperial College London from September 2011 to December 2017. Andy started their career at Pfizer in June 1980 and worked as a Research Fellow until August 2011.

Andy Bell earned their Doctor of Philosophy - PhD in Medicinal and Pharmaceutical Chemistry from Imperial College London from 2011 to 2017. Andy also attended the University of York from 1975 to 1978, although it is not specified whether they obtained a degree or field of study from there. Additionally, they pursued another Doctor of Philosophy - PhD in Medicinal and Pharmaceutical Chemistry from Imperial College London, but the specific start and end dates are unknown.